JASPER YUEN: Open Payments
NPI 1346900362 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,824 in 89 payments from 24 companies in 2025. Trend: 2023 $1,159 · 2024 $1,888 · 2025 $1,824
Food & beverage: $1,824
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 16 | $284 |
| AstraZeneca Pharmaceuticals LP | 8 | $284 |
| Novo Nordisk Inc | 9 | $202 |
| ABBVIE INC. | 8 | $174 |
| Phathom Pharmaceuticals, Inc. | 11 | $157 |
| Amgen Inc. | 5 | $90 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Exact Sciences Corporation | 3 | $75 |
| Optinose US, Inc. | 4 | $73 |
| Axsome Therapeutics, Inc. | 4 | $72 |
Products named: MOUNJARO, BREZTRI, VOQUEZNA, JARDIANCE, Wegovy, OTEZLA, UBRELVY, FARXIGA.
Industry payments across FL — which companies pay providers there.
